NCT00676312
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- Novartis Investigative site Basel, Switzerland
Clinical trial condition
Osteoporosis, Postmenopausal
Explore clinical trials studying Osteoporosis, Postmenopausal. Study availability and eligibility vary by location and protocol.
277 public trials
18 recruiting studies
Osteoporosis, Postmenopausal trial results
Completed
Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
NCT00168909
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Falls, +9 more
- Locations
-
- Centre for Muscle and Bone Research, Charité - Campus Benjamin Franklin Berlin, Germany
- Centre for Muscle and Bone Research, Aerpah-Kliniken Esslingen Stuttgart, Germany
NCT00221312
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT00670501
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Capital Federal, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nedlands, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria
NCT00670319
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad de Buenos Aires, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelburg, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria
NCT00453492
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- Sanofi-Aventis Istanbul, Turkey (Türkiye)
Completed
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
NCT00632216
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
Not specified
NCT00290212
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- Clinical Research Center, University Hospital of North Norway Tromsø, Norway
- Haukeland University Hospital Bergen, Norway
NCT00165204
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Breast Cancer, +13 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Completed
Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
NCT00238745
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
Not specified